Cargando…
Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4’-deoxy-4’-fluoro-Thomsen–Friedenreich epitope
The development of selective anticancer vaccines that provide enhanced protection against tumor recurrence and metastasis has been the subject of intense research in the scientific community. The tumor-associated glycoprotein MUC1 represents a well-established target for cancer immunotherapy and has...
Autores principales: | Johannes, Manuel, Reindl, Maximilian, Gerlitzki, Bastian, Schmitt, Edgar, Hoffmann-Röder, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311645/ https://www.ncbi.nlm.nih.gov/pubmed/25670999 http://dx.doi.org/10.3762/bjoc.11.15 |
Ejemplares similares
-
Glycoamino Acid Analogues of the Thomsen–Friedenreich
Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of
Novel Antiproliferative Factor Glycopeptides
por: Siddiqui, Maqbool A., et al.
Publicado: (2017) -
The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
por: Dippold, W, et al.
Publicado: (1990) -
Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
por: Sindrewicz, Paulina, et al.
Publicado: (2016) -
The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer
por: Kurtenkov, Oleg, et al.
Publicado: (2018) -
Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability
por: Leão, Beatriz, et al.
Publicado: (2021)